Phone no.

+38 (044) 277–8–277

(044) 277–8–277

(800) 50 51 58

Addresses

27 Malyshko Str.,

Pliuty village, Obuhovskiy district,

Ukraine, Kyiv region 08720

info@lisod.com

4A Chornomorska Str., Chernivtsi, Ukraine, 58022

LISOD Team: Best among the Best

November 4, 2019

Chemotherapy department of LISOD Hospital is headed by Zoya Shklyar (Israel), a clinical oncologist and one of the best chemotherapists of Israel.

 

For more than 30 years Zoya Yefimovna has been dealing with treatment of oncological diseases of different localization, the doctor has contributed significantly to the development of modern methods of cancer treatment. Among main directions of the doctor’s investigatory activity and clinical practice are breast, prostate, lung tumors, as well as melanoma. For several recent years she has been a doctor-consultant for oncological diseases, besides she has been taking the position of the director of female health institute in the Medical Centre Chorev (Haifa, Israel).

 

A lot of LISOD patients are acquainted with Zoya Yefimovna, as she used to work as a clinical oncologist in LISOD until 2011. Now the doctor returned to the hospital – with invaluable skills, big abilities and experience, with the goal of making treatment even more efficient.

 

Real professionals work in chemotherapy department. Their knowledge, as well as application of the newest medications allows reaching successful results in treatment of patients. Medications of only high quality are used in the hospital for treatment. Infusions are made strictly according to the international protocols; both periodicity and staging are followed properly.

 

As of today LISOD Hospital is the leader in using targeted and immunotherapeutic drugs and applies them wider than any other oncological hospital od Ukraine.

 

 

Apply for consultation in LISOD:

 0-800-500-110 – free in Ukraine;

 +38-044-277-8-277 – daily from 8 a.m. till 8 p.m.

TOP News & Events

See all »
MRI in LISOD. How it works

Hospital of Israeli Oncology LISOD operates a new MRI scanner. Neither COVID-19 pandemic, nor a full-fledged invasion or hostilities stopped us...

December 6, 2022